[Caesar Health] Announcement: Board of Directors Approved the Company's First Quarter 2026 Consolidated Financial Report
Key facts
- [Caesar Health] Announcement: Board of Directors Approved the Company's First Quarter 2026 Consolidated Financial Report
- Caesar Health announced on May 12, 2026, its Q1 2026 consolidated financial report, approved by the Board of Directors. The quarter's revenue reached 611.528 million JPY, net profit was 88.416 million JPY, and EPS was 1.21 JPY, demonstrating solid financial performance.
- Source: PR Times
- Date: May 12, 2026
Direct answer
Caesar Health announced on May 12, 2026, its Q1 2026 consolidated financial report, approved by the Board of Directors. The quarter's revenue reached 611.528 million JPY, net profit was 88.416 million JPY, and EPS was 1.21 JPY, demonstrating solid financial performance.
- Citation
- [Caesar Health] Announcement: Board of Directors Approved the Company's First Quarter 2026 Consolidated Financial Report (May 12, 2026), PR Times
- Source
- PR Times
- Date
- May 12, 2026
Caesar Health announced on May 12, 2026, its Q1 2026 consolidated financial report, approved by the Board of Directors. The quarter's revenue reached 611.528 million JPY, net profit was 88.416 million JPY, and EPS was 1.21 JPY, demonstrating solid financial performance.
📋 Article Processing Timeline
- 📰 Published: May 12, 2026 at 09:00
- 🔍 Collected: May 13, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 13, 2026 at 12:02 (4h 2m after Collected)
2. Date of approval by the Audit Committee: 115/05/12
3. Reporting period for financial report or annual self-reported financial information (YYYY/MM/DD~YYYY/MM/DD): 115/01/01~115/03/31
4. Cumulative operating revenue from January 1 to the end of the period (thousand yen): 611,528
5. Cumulative gross profit (loss) from January 1 to the end of the period (thousand yen): 237,424
6. Cumulative operating profit (loss) from January 1 to the end of the period (thousand yen): 117,537
7. Cumulative profit (loss) before tax from January 1 to the end of the period (thousand yen): 116,319
8. Cumulative net profit (loss) for the period from January 1 to the end of the period (thousand yen): 88,416
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of the period (thousand yen): 87,774
10. Cumulative earnings (loss) per share from January 1 to the end of the period (yen): 1.21
11. Total assets at the end of the period (thousand yen): 2,963,735
12. Total liabilities at the end of the period (thousand yen): 558,812
13. Equity attributable to owners of the parent company at the end of the period (thousand yen): 2,359,040
14. Other matters to be stated: None
FAQ
What are the key facts in this article?
Caesar Health announced on May 12, 2026, its Q1 2026 consolidated financial report, approved by the Board of Directors. The quarter's revenue reached 611.528 million JPY, net profit was 88.416 million JPY, and EPS was 1.21 JPY, demonstrating solid financial performance.
What is the direct answer?
Caesar Health announced on May 12, 2026, its Q1 2026 consolidated financial report, approved by the Board of Directors. The quarter's revenue reached 611.528 million JPY, net profit was 88.416 million JPY, and EPS was 1.21 JPY, demonstrating solid financial performance.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-1817-2026-05-12-15cdd4f1 | May 12, 2026